• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday

    8/1/22 5:27:59 AM ET
    $AHG
    $AKTX
    $AMTD
    $AMTX
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AHG alert in real time by email

    Gainers

    • Getty Images Holdings, Inc. (NYSE:GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB).
    • Brookline Capital Acquisition Corp. (NASDAQ:BCAC) gained 127.3% to settle at $22.71.
    • AMTD Digital Inc. (NYSE:HKD) surged 122.4% to settle at $400.25 on continued post-IPO volatility.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) climbed 68.3% to close at $3.13 after declining 5% on Thursday.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) gained 51.6% to close at $0.7930. The U.S. Food and Drug Administration (FDA) recently declined to issue an Emergency Use Authorization (EUA) for NRx Pharmaceuticals’ lead drug ZYESAMI (aviptadil) for subgroup of patients with critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) gained 40.2% to close at $4.74.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) gained 38.1% to settle at $24.82 on continued volatility after the company completed its SPAC merger agreement last month.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) surged 37.2% to settle at $2.73. GeoVax Labs announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus.
    • MAIA Biotechnology, Inc. (NYSE:MAIA) gained 30% to close at $5.80. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) jumped 28.7% to settle at $2.47.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) gained 27% to close at $0.2694 after gaining over 6% on Thursday.
    • Regional Health Properties, Inc. (NYSE:RHE) surged 26.8% to settle at $4.69.
    • AXT, Inc. (NASDAQ:AXTI) shares climbed 24.9% to close at $8.77 after the company reported better-than-expected Q2 EPS.
    • Nano Labs Ltd (NASDAQ:NA) gained 23.3% to settle at $9.62 amid post-IPO volatility after the stock opened for trade earlier in the month.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) gained 23.3% to close at $1.48. Mobiquity Technologies looks to launch a multi-national ad campaign using the Mobiquity CryptoGraph technology to drive awareness for the BlockBusters token on August 2.
    • Sonder Holdings Inc. (NASDAQ:SOND) rose 23% to close at $1.55.
    • TuanChe Limited (NASDAQ:TC) jumped 23% to settle at $1.82.
    • AMTD IDEA Group (NYSE:AMTD) gained 22.2% to settle at $1.76.
    • FaZe Holdings Inc. (NASDAQ:FAZE) jumped 22% to close at $13.09 amid continued post-IPO volatility.
    • Mammoth Energy Services, Inc. (NASDAQ:TUSK) climbed 21.8% to close at $2.91 after the company reported better-than-expected Q2 sales results and EPS results were higher year over year.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 21% to close at $7.09. The company entered into an agreement with Ace Hardware USA to sell 35 products across 5,500 stores.
    • Akari Therapeutics, Plc (NASDAQ:AKTX) gained 20.6% to settle at $1.14.
    • Akari Therapeutics reported results from recent pre-clinical studies of Investigational PASylated Nomacopan that support the potential to advance research toward IND/IMPD for clinical trials in geographic atrophy.
    • Mitek Systems, Inc. (NASDAQ:MITK) rose 20.6% to close at $10.88 after the company reported better-than-expected Q3 results.
    • Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) rose 19.6% to close at $1.71. Ayala Pharmaceuticals recently filed a request for the withdrawal of the Registration Statement on Form S-1.
    • Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) gained 19.4% to close at $17.25. Shares of solar companies traded higher in sympathy with First Solar, which reported strong Q2 results and raised guidance.
    • World Fuel Services Corporation (NYSE:INT) climbed 19.1% to close at $27.72 after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • Nouveau Monde Graphite Inc. (NYSE:NMG) rose 18.4% to close at $4.77.
    • Sunworks, Inc. (NASDAQ:SUNW) gained 18.4% to close at $2.38. Shares of solar companies traded higher in sympathy with First Solar, which reported strong Q2 results and raised guidance
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) rose 17.8% to settle at $3.17 as stocks related to clean energy continue to gain amid optimism towards US climate change efforts.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) gained 17.6% to settle at $16.21.
    • InflaRx N.V. (NASDAQ:IFRX) gained 17.6% to settle at $2.74. InflaRX recently announced plans to apply for Emergency Use Authorization from the FDA for vilobelimab for the treatment of critically ill COVID-19 patients.
    • CVRx, Inc. (NASDAQ:CVRX) climbed 17% to close at $8.83 after the company reported better-than-expected Q2 sales results.
    • Core Scientific, Inc. (NASDAQ:CORZ) gained 16.7% to close at $2.51.
    • Clearfield, Inc. (NASDAQ:CLFD) gained 16.5% to settle at $98.55 after the company reported better-than-expected Q3 EPS and sales results.
    • OKYO Pharma Limited (NASDAQ:OKYO) jumped 15.8% to close at $2.3501.
    • Data I/O Corporation (NASDAQ:DAIO) gained 15.3% to close at $3.54 following strong Q2 results.
    • Carrols Restaurant Group, Inc. (NASDAQ:TAST) gained 15.3% to settle at $2.49.
    • Aemetis, Inc. (NASDAQ:AMTX) climbed 15% to settle at $7.35.
    • Sequans Communications S.A. (NYSE:SQNS) gained 14.1% to close at $3.00.
    • SAI.TECH Global Corporation (NASDAQ:SAI) gained 13.9% to close at $6.14.
    • U.S. Silica Holdings, Inc. (NYSE:SLCA) gained 13% to close at $13.83 after the company reported better-than-expected Q2 EPS and sales results.
    • Q&K International Group Limited (NASDAQ:QK) rose 12.3% to close at $2.10.
    • Transocean Ltd. (NYSE:RIG) rose 12.3% to close at $3.38.
    • Haynes International, Inc. (NASDAQ:HAYN) rose 12.2% to settle at $38.66 after the company reported better-than-expected Q3 results.
    • Omeros Corporation (NASDAQ:OMER) climbed 11.4% to close at $4.98 after the FDA granted Orphan Drug Designation to OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria.
    • DAVIDsTEA Inc. (NASDAQ:DTEA) gained 10.4% to close at $1.49.
    • Amazon.com, Inc. (NASDAQ:AMZN) jumped 10.4% to close at $134.95 after the company reported better-than-expected results for its second quarter. The company said it expects-third quarter net sales to be in a range of $125 billion to $130 billion, up 13% to 17% year-over-year.
    • Five9, Inc. (NASDAQ:FIVN) gained 9.9% to close at $108.12 after the company reported better-than-expected Q2 results and issued strong guidance.
    • CHW Acquisition Corporation (NASDAQ:CHWA) gained 9.2% to close at $10.10. CHW Acquisition’s stockholders approved proposed merger transaction with Wag Labs, Inc.
    • Deckers Outdoor Corporation (NYSE:DECK) gained 9% to close at $313.21 after the company reported better-than-expected Q1 EPS and sales results.
    • Chevron Corporation (NYSE:CVX) rose 8.9% to settle at $163.78 after the company reported better-than-expected Q2 EPS and sales results.
    • Chart Industries, Inc. (NYSE:GTLS) gained 8.9% to close at $195.09 following Q2 earnings.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) gained 8.5% to close at $2.56.
    • Graham Corporation (NYSE:GHM) gained 8.3% to close at $7.15 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Rite Aid Corporation (NYSE:RAD) rose 7.9% to close at $8.23. Traders circulated Dealreporter chatter that activists might be eyeing the company.
    • Houston American Energy Corp. (NYSE:HUSA) gained 7% to close at $4.41.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 6.6% to close at $2.90.
    • Resources Connection, Inc. (NASDAQ:RGP) rose 6% to close at $21.46 following upbeat Q4 earnings.
    • Apple Inc. (NASDAQ:APPL) rose 3.3% to close at $162.51 as the company reported better-than-expected results for its fiscal year third-quarter, helped by strong iPhone and iPad sales.


    Losers

    • Virax Biolabs Group Limited (NASDAQ:VRAX) tumbled 74% to settle at $5.40 on Friday as the stock pulled back after surging recently following the company's announcement of a distribution of Monkeypox and Varicella-Zoster Viruses Real Time PCR Detection Kits.
    • Lottery.com Inc. (NASDAQ:LTRY) shares dipped 63.8% to close at $0.2950 on Friday after the company in an SEC filing said its board determined it does not have sufficient financial resources to fund operations.
    • Avaya Holdings Corp. (NASDAQ:AVYA) shares tumbled 57% to settle at $0.8986 after the company cut Q3 revenue guidance. Craig-Hallum downgraded Avaya from Buy to Hold.
    • Holley Inc. (NYSE:HLLY) fell 36.9% to close at $7.99 after the company lowered its FY22 sales guidance below analyst estimates.
    • Nutriband Inc. (NASDAQ:NTRB) fell 34.1% to close at $5.12.
    • TOP Financial Group Limited (NASDAQ:TOP) dropped 29.9% to close at $9.99.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) dropped 24.6% to close at $0.6359.
    • Athersys, Inc. (NASDAQ:ATHX) dipped 23.4% to close at $0.2491.
    • Roku, Inc. (NASDAQ:ROKU) shares fell 23.1% to settle at $65.52 after the company reported weaker-than-expected financial results for its second quarter and withdrew its full-year revenue growth guidance. Roku said it expects third-quarter revenue to increase about 3% year-over-year to $700 million.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) declined 23.1% to close at $17.19 after the FDA announced there is currently no human data demonstrating the efficacy of Tpoxx for the treatment of Monkeypox.
    • Femasys Inc. (NASDAQ:FEMY) dipped 20.6% to close at $1.70.
    • VivoPower International PLC (NASDAQ:VVPR) declined 18.1% to settle at $1.13. VivoPower International reported pricing of $5.5 million offering.
    • Cryptyde, Inc. (NASDAQ:TYDE) dropped 17.8% to close at $1.11.
    • BiomX Inc. (NYSE:PHGE) fell 16.2% to settle at $0.8972.
    • Missfresh Limited (NASDAQ:MF) shares dropped 14.9% to close at $0.1151 after the company adopted significant business strategy adjustments. The company received RMB200 million equity investment pursuant to investment agreement and highlighted temporary shutdown of on-demand distributed mini warehouse.
    • ObsEva SA (NASDAQ:OBSV) fell 14.9% to close at $0.2570 as the company reported the resignation of Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research & Development, effective September 30, 2022.
    • SKYX Platforms Corp. (NASDAQ:SKYX) fell 14.8% to close at $5.99. Benchmark, on Thursday, initiated coverage on the stock with a Buy rating and announced a $15 price target.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) declined 14.5% to close at $4.36.
    • Akso Health Group (NASDAQ:AHG) dropped 14.4% to settle at $0.89.
    • Green Giant Inc. (NASDAQ:GGE) fell 14% to close at $2.28.
    • Bridgford Foods Corporation (NASDAQ:BRID) declined 14% to close at $12.64.
    •  
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 13.5% to close at $1.67.
    • Great Panther Mining Limited (NYSE:GPL) fell 13.5% to settle at $0.96.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 12.9% to close at $2.64.
    • Nuvalent, Inc. (NASDAQ:NUVL) dropped 12.6% to settle at $14.86.
    • VolitionRx Limited (NYSE:VNRX) fell 11% to close at $2.03 after the company reported pricing of $6 million underwritten public offering of common stock.
    • Avantor, Inc. (NYSE:AVTR) shares fell 10.2% to close at $29.02 after the company reported worse-than-expected Q2 EPS and sales results.
    • Bausch Health Companies Inc. (NYSE:BHC) dipped 9.4% to close at $4.62 after several analysts downgraded the stock amid concerns. The stock has fallen over the past two sessions amid an expected court decision in the XIFAXAN patent litigation.
    • QualTek Services Inc. (NASDAQ:QTEK) fell 9% to close at $1.21.
    • Intel Corporation (NASDAQ:INTC) fell 8.6% to close at $36.31 after the company reported worse-than-expected Q2 EPS and sales results. The company also issued Q3 and FY22 EPS and sales guidance below analyst estimates.
    • DexCom, Inc. (NASDAQ:DXCM) fell 5.6% to close at $82.08 after the company reported worse-than-expected Q2 EPS and sales results.
    Get the next $AHG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHG
    $AKTX
    $AMTD
    $AMTX

    CompanyDatePrice TargetRatingAnalyst
    Transocean Ltd (Switzerland)
    $RIG
    2/10/2026$5.25Hold → Sell
    Pareto
    Graham Corporation
    $GHM
    2/10/2026Market Perform → Outperform
    Northland Capital
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    Roku Inc.
    $ROKU
    2/6/2026$105.00Perform → Outperform
    Oppenheimer
    Amazon.com Inc.
    $AMZN
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    Data I/O Corporation
    $DAIO
    2/2/2026$5.00Buy
    Ladenburg Thalmann
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    More analyst ratings

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Asher Daniel bought $62,974 worth of shares (12,300 units at $5.12) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/28/26 4:31:28 PM ET
    $SQNS
    Semiconductors
    Technology

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Large owner Asher Daniel bought $222,513 worth of shares (42,260 units at $5.27) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/22/26 5:09:00 PM ET
    $SQNS
    Semiconductors
    Technology

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Transocean downgraded by Pareto with a new price target

    Pareto downgraded Transocean from Hold to Sell and set a new price target of $5.25

    2/10/26 11:10:50 AM ET
    $RIG
    Oil & Gas Production
    Energy

    Graham upgraded by Northland Capital

    Northland Capital upgraded Graham from Market Perform to Outperform

    2/10/26 8:59:35 AM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    Monness Crespi & Hardt reiterated coverage on Amazon with a new price target

    Monness Crespi & Hardt reiterated coverage of Amazon with a rating of Buy and set a new price target of $280.00 from $300.00 previously

    2/6/26 8:23:18 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AHG
    $AKTX
    $AMTD
    $AMTX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Appio Thomas was granted 1,137,862 shares, increasing direct ownership by 64% to 2,921,111 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    2/11/26 6:30:02 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, General Counsel Carson Seana was granted 137,922 shares, increasing direct ownership by 28% to 637,507 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    2/11/26 6:24:17 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Gross Matthew Lee claimed ownership of 15,203 shares (SEC Form 3)

    3 - GRAHAM CORP (0000716314) (Issuer)

    2/11/26 4:34:34 PM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    $AHG
    $AKTX
    $AMTD
    $AMTX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.

    SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)

    2/11/26 7:24:32 PM ET
    $PHGE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 424B5 filed by Xilio Therapeutics Inc.

    424B5 - Xilio Therapeutics, Inc. (0001840233) (Filer)

    2/11/26 5:16:58 PM ET
    $XLO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by VolitionRX Limited

    DEF 14A - VOLITIONRX LTD (0000093314) (Filer)

    2/11/26 5:05:44 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Getty Images and NASCAR Renew Multi-Year Agreement

    A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Getty Images (NYSE:GETY), a preeminent global visual content creator and marketplace, today announced the renewal of its long-standing partnership with NASCAR, extending its role as NASCAR's Official Photography Partner, a designation it has held since 2006. The agreement sees Getty Images' team of specialized motorsport photographers deliver high-quality imagery from all races and events in the NASCAR series, including NASCAR Cup Series™, NASCAR O'Reilly Auto Parts Series™, and NASCAR CRAFTSMAN Truck Series™. With exclusive, behind-the-scenes access, Getty

    2/12/26 8:00:00 AM ET
    $GETY
    Real Estate

    Mitek Strengthens Its Unassisted Video Verification Solution for the Spanish Market as AI-Driven Identity Fraud Accelerates

    SEPBLAC-compliant digital onboarding helps regulated entities stay ahead of deepfakes and digital manipulation without adding friction Mitek Systems (NASDAQ:MITK), a global leader in digital identity verification and fraud prevention, today announced enhancements to its SEPBLAC-compliant digital onboarding capabilities for the Spanish market, designed to help regulated entities defend against a rapidly escalating wave of AI-driven identity fraud. The enhancements strengthen Mitek's unassisted video verification solution, used across Spain for SEPBLAC‑compliant remote identity verification. Unassisted video verification has long been a regulatory requirement for financial institutions an

    2/12/26 2:30:00 AM ET
    $MITK
    Computer peripheral equipment
    Technology

    Xilio Therapeutics Announces Pricing of Underwritten Offering

    WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the pricing of an underwritten offering of pre-funded warrants to purchase 74,780,300 shares of common stock at a price to investors of $0.5349 per pre-funded warrant (the "pre-funded warrants"). Each pre-funded warrant is exercisable for one share of common stock at an exercise price of $0.0001 per share. The pre-funded warrants will be exercisable immediately and will be exercisable until all of the pre-funded warrants are exercised in full. The offering is

    2/11/26 9:34:13 PM ET
    $XLO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Leadership Updates

    Live Leadership Updates

    View All

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Volition Announces the Appointment of New Distributor for Nu.Q® Discover

    HENDERSON, Nev., Feb. 10, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announces the appointment of Medical & Biological Laboratories Co. Ltd (MBL) as a non-exclusive distributor of its Nu.Q® Discover assays in Japan. Dr Jasmine Kway, Chief Executive Officer, Singapore Volition commented: "We are delighted to be working with MBL, a leading provider of clinical research tools in Japan, with a particular focus and track record in autoimmune diseases. "Through our Nu.Q® Discover pillar, we are now serving close to 100 clients worldwide, including many top pharma and diagnostic companies, accelerating disease research and drug developme

    2/10/26 8:07:00 AM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer

    Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli will lead the clinical and regulatory strategy to advance the company's development program in neuropathic corneal pain (NCP), leveraging urcosimod's FDA Fast Track designationThis appointment, following the recent CEO appointment, further strengthens OKYO's world-class ophthalmology leadership team LONDON and NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neur

    2/10/26 8:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Financials

    Live finance-specific insights

    View All

    Eos Energy Enterprises Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

    EDISON, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the "Company"), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced it will release its fourth quarter and full year 2025 financial results before the U.S. market opens on February 26, 2026. A conference call to discuss its results will take place the same morning at 8:30 a.m. Eastern Time. Eos partners with Say Technologies to allow retail and institutional shareholders to submit and vote on questions ahead of the earnings call. A select

    2/11/26 4:30:00 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

    Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety profile Company planning for rapid advancement of SENTI-202 into R/R AML pivotal study and evaluating indication expansion to include newly diagnosed AML and pediatric AML; Preparing for FDA discussions in the first half of 2026 SENTI-202 has received Regenerative Medicine Advanced Therapy (RMAT) designation, which may enable an expedited development and review process SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) --  Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generatio

    2/11/26 8:35:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Avantor® Reports Fourth Quarter and Full Year 2025 Results

    Revival program underway, including relaunch of VWR brand, implementation of critical manufacturing and supply chain improvements, and upgrades to e-commerce channel Fourth Quarter 2025 Net sales of $1.66 billion, decrease of 1%; organic decrease of 4%Net income of $52 million; Adjusted EBITDA of $252 millionDiluted GAAP EPS of $0.08; adjusted EPS of $0.22Operating cash flow of $153 million; free cash flow of $117 millionFull Year 2025 Net sales of $6.55 billion, decrease of 3%; organic decline of 3%Net loss of $530 million; Adjusted EBITDA of $1,069 millionDiluted GAAP loss per share of $0.78; adjusted EPS of $0.90Operating cash flow of $624 million; free cash flow of $496 millionRADNOR, Pa

    2/11/26 6:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care